About MADGenesis
We are a multidisciplinary team of biomedical engineers, clinicians and AI researchers developing micro-robotic capsules and training simulators to improve early detection of colorectal cancer.
WHY MADGenesis?
MADGenesis aims to become a key contender in early cancer diagnosis, clinical training, and AI-driven diagnostics, starting in the UK and growing internationally, with strong NHS alignment, a scalable commercial model, and an increasingly pressing clinical need. The business is founded on the principle that early detection and high-quality clinical training are key to reducing preventable deaths from colorectal cancer (CRC), both in aging and under age 50, populations like the UK. MADGenesis enters the market at a moment when policies and demand are in alignment for rapid adoption of high-quality medical training programs and non-invasive, AI-powered screening solutions..
VISION & MISION:
Our vision is to help the NHS diagnose colorectal cancer earlier, safer, and more impartial by increasing screening uptake among eligible and underserved communities and decreasing reliance on invasive, capacity-constrained procedures. By facilitating precise, patient-centered diagnostics and reliable clinical performance, we hope to support national priorities for early cancer diagnosis, workforce resilience, and digitally enabled care. MADGenesis aims to improve sustainable screening routes within the NHS and similar public health systems, minimise late-stage presentation, and reduce preventable mortality using UK-originated medical innovation. Our mission is to create and market an integrated AI-driven MedTech platform that combines an AI-guided, minimally invasive capsule-based screening technology (MAD Alpha) with high-fidelity colonoscopy simulation (MAD Syncro). We hope to boost screening participation, lessen the burden of endoscopic services, and enhance detection quality by enhancing clinician training, lowering operator variability, and facilitating non-invasive diagnostic options. Our system, which was created with NHS workflows, UKCA/MHRA alignment, and phased deployment in mind, offers scalable clinical value while creating a long-lasting, globally applicable UK health technology enterprise.
Team
Alok Singh
Founder
Product Architecture, Simulation & AI Lead
Tithi Sen Chaudhuri
Co-Founder
Simulation, AI, Documentation & Technical Lead
Md Sanoar Hossen
Co-Founder
Clinical Engineering, Safety, Workflow Lead
Impact & Opportunity
Our solution reduces patient discomfort, lowers costs for health systems, and enables earlier detection — improving outcomes worldwide.